INTRODUCTION
Mature follicular B cells are largely responsible for thymus (T)-dependent antigenic responses. Two receptors critical for follicular B cell maintenance and expansion are the B cell antigen receptor (BCR) and the B-cell-activating factor receptor (BAFF-R). BCR is critical for antigen-responsive expansion and maintenance of the mature B cell pool ( Lam et al., 1997 ) . BAFF-R (and BAFF) is critical for the survival of maturing transitional B cells ( Harless et al., 2001 ; O'Connor et al., 2004 ; Schiemann et al., 2001 ) , enhances follicular B cells, enhances antigen-responsive B cell expansion in vitro ( Huang et al., 2004 ; Rickert et al., 2011 ; Schweighoffer et al., 2013 ) , and strengthens T cell-dependent and independent humoral immune responses ( Do et al., 2000 ; Litinskiy et al., 2002 ) . Indeed, whereas initiation of germinal center formation was found to be independent of BAFF, the B cell responsiveness to antigens (via the BCR) is impaired in BAFF-signaling-deficient mice ( Rahman et al., 2003 ; Vora et al., 2003 ) .
BCR and BAFF-R are known to signal to NFκB via two distinct pathways: the NEMOdependent "canonical" pathway and the NEMO-independent "noncanonical" pathway, respectively. Activated BCR recruits the Carma1-Bcl10-Malt1-containing complex to the membrane, triggering NEMO ubiquitination and activation of the NEMO-containing IKK complex. This leads to nuclear translocation of preexisting RelA-and cRel-containing NFκB dimers from the latent IκB-inhibited cytoplasmic complexes ( Hayden and Ghosh, 2008 ) . BAFF-R stimulation sequesters TRAF3, resulting in the stabilization of NIK and activation of a NEMO-independent IKK1 kinase complex. This stimulates p100 processing to p52 and results in nuclear accumulation of RelB:p52 dimers ( Claudio et al., 2002 ) .
Recent studies have begun to address the molecular basis for the functional interactions between BCR and BAFF-R. Tonic BCR signaling and associated canonical pathway activity are critical for the constitutive expression of the Nfkb2 gene generating p100 substrate for NIK/IKK1-dependent processing and production of RelB:p52 dimer in maturing B cells ( Cancro, 2009 ; Stadanlick et al., 2008 ) . Similarly, lymphotoxin-beta receptor-responsive noncanonical pathway activation was found to be dependent on constitutive canonical signaling ( Basak et al., 2008 ) . In the context of resting B cells, RelB is a presumed mediator of BAFF's survival functions dependent on tonic BCR. Extending this model to proliferating B cells suggests that heightened BCR-responsive canonical activity might strengthen BAFFmediated activation of RelB. In other words, a costimulatory role of BAFF in the expansion of activated B cells might be achieved through RelB-mediated enhanced cell survival. However, there are indications that BAFF may in fact not only enhance cell survival but contribute to cell cycle entry of mature follicular B cells following antigenic stimulation ( Allman et al., 2001 ; Do et al., 2000 ; Huang et al., 2004 ; Patke et al., 2006 ) . It is unknown whether this function may also involve NFκB signaling or be entirely mediated by other signaling axes known to be activated by BAFF, such as phosphatidylinositol 3-kinase (PI3K) or mitogen-activated protein kinase/ERK ( Jellusova et al., 2013 ; Mackay and Schneider, 2009 ; Mackay et al., 2007 ; Rickert et al., 2011 ) , which are also mediators of BCR signaling ( Srinivasan et al., 2009 ) and potential crosstalk regulators ( Schweighoffer et al., 2013 ) .
Here, we addressed the role of the NFκB-signaling system in mediating BAFF's functions in both maturing as well as proliferating B cells using quantitative cell biology, biochemistry, and mathematical modeling. In particular, we offer genetic evidence that RelB is indeed critical for BAFF-induced survival of maturing B lymphocytes in vitro but the costimulatory effect of BAFF in BCR-triggered population expansion is not based on enhanced B cell survival or elevated RelB activity. Instead, BAFF costimulation augments BCR-triggered cRel activation and the fraction of B cells entering the proliferative program. Quantitative analysis of the NFκB network reveals that cRel hyperactivation is achieved by BAFF neutralizing the inhibitory effect of BCR-induced p100, which was shown to assemble into a multimeric IκBsome ) with associated IκBδ activity ( Basak et al., 2007 ; Shih et al., 2009 ) .
RESULTS

BAFF-R Enhances BCR-Triggered B Cell Expansion
Prior work has established that BCR and BAFF-R activate distinct NFκB-signaling pathways, the so-called canonical, NEMO-dependent and the noncanonical, NEMOindependent pathways, respectively ( Figure 1A ). Whereas the primary transcriptional effector of the former is NFκB cRel, which enhances cell survival and may initiate the Bcell-proliferative program, the latter is known to activate RelB. Both receptors also activate other signaling pathways such as PI3K and ERK that contribute to their physiological functions ( Mackay et al., 2007 ; Otipoby et al., 2008 ; Ramakrishnan et al., 2004 ) .
We asked whether BAFF costimulation would enhance BCR-triggered B cell expansion via enhanced cell survival or whether other signaling crosstalk mechanisms might be involved. Using the cell-tracking dye carboxyfluorescein succinimidyl ester (CFSE), we monitored splenic B cell expansion following BCR crosslinking with anti-immunoglobulin M (IgM). Costimulation of BAFF-R increased this B cell expansion ( Figures 1B and S1 ), confirming previous studies ( Craxton et al., 2007 ; Huang et al., 2004 ; Schweighoffer et al., 2013 ; Stadanlick et al., 2008 ) . To determine how BAFF affected B cell population dynamics, we employed the software tool FlowMax ( Shokhirev and Hoffmann, 2013 ) , which deconvolutes dye dilution data to determine the fraction of cells entering the proliferative program (pF) and the associated cell division (Tdiv) as well as cell survival (Tdie) times. This automated interpretation of CFSE data suggest that BAFF not only increased the lifetime of B cells (from 40 to 61 hr) but also increased the fraction of responding cells entering the proliferative program from 5% to 15% ( Figure 1C) . However, the time required for first cell division remained relatively constant at 43-48 hr. Indeed, 7-amino-actinomycin D (7AAD) staining revealed fewer dying cells at 24 hr ( Figure 1D ), but at a longer time course, the number of live cells actually increased with BAFF ( Figure 1E ), consistent with previous reports that BAFF is able to contribute to cell cycle entry as well ( Do et al., 2000 ; Huang et al., 2004 ; Patke et al., 2006 ) .
The transcriptomic response to costimulation, as revealed by RNA sequencing (RNA-seq) analysis, included a substantial number of genes (171; Figures 2A and 2B ), many of which were dependent on BAFF costimulus (87 were reduced >2 0.5 -fold in single anti-IgM stimulation conditions). Gene ontology analysis revealed terms like "metabolic process" and "biological regulation" scoring highly, whereas regulation of cell death or cell proliferation did not ( Figure 2C ). Remarkably, motif analysis of the regulatory region (−1,000 to +300 of the transcription start site) of these hyperinduced genes revealed the κB motif as being substantially overrepresented. In particular, using previously characterized NFκB-binding motifs ( Siggers et al., 2012 ) , we found that the cRel:p50-binding motif is present in 56% of the proximal regulatory regions of these hyperexpressed genes, regardless of their gene ontology categorization. Of these 81 "late" hyperinduced genes, we identified some candidates involved in prosurvival and cell cycle processes ( Figures 2B and 2D) . Examination of these hyperexpressed regulators of survival and cell cycle by quantitative PCR revealed that their full expression depended on cRel ( Figure 2E ).
To determine which NFκB activity was hyperinduced, we examined NFκB DNA-binding activities biochemically using electrophoretic mobility shift assays coupled with antibody supershift to ablate all but the NFκB dimer of interest. Anti-IgM stimulation was found to induce a transient cRel activity within the first few hours, followed by a return to basal levels by 24 hr ( Figure 2F ). BAFF stimulation alone activated cRel similarly and also resulted in long-lasting RelB DNA-binding activity. Upon costimulating BCR and BAFF-R, we observed surprisingly little change in the induced RelB activity but found that cRel DNAbinding activity was enhanced in amplitude at 12 hr as well as prolonged in duration up to 40 hr. Quantitation of the data confirmed that costimulation provides for "superactivated" cRel, but not RelB ( Figure 2F, right) . Interestingly, RelA-containing dimers are rapidly induced upon solitary anti-IgM or BAFF treatment, but basal levels are restored within roughly 6 hr. And like RelB, these kinetics are nearly identical in costimulated conditions. We examined expression of these NFκB family members at both the mRNA and the protein level ( Figures S3A and S3B ) but found little to no increase in the costimulation state compared to individual BCR or BAFF-R stimulation, in contrast to the results of the DNAbinding activity analysis.
Differential Requirements for cRel and RelB in Resting and Proliferating B Cells
We then investigated the genetic requirement of cRel and RelB NFκB family members in mediating BAFF's functions in B cells. Mature follicular B cells subsets are the strongest responders to anti-IgM-induced proliferative signals, and their development is unaffected by lack of either cRel or RelB, though RelB −/− mice lack marginal zone B cells ( Weih et al., 2001 ). We first examined in vitro survival of total B cell population cultured in BAFF to find significant impairment in the absence of RelB ( Figure 3A) and also a reduction, though less severe, in the absence of cRel. Charting a longer time course confirmed the importance of RelB and, to a lesser extent, cRel in BAFF-R-induced survival of B cells in vitro ( Figure 3A , right). We note, however, that in vivo Relb and also Ikk1 appear to be redundant with other pathways, as the respective knockouts do not show deficiencies in B cell numbers ( Jellusova et al., 2013 ) . Turning to BAFF's role as a costimulus during BCR-triggered B cell expansion, fluorescence-activated cell sorting (FACS) analysis of the CFSE-labeled total B cell population revealed that enhanced B cell expansion in response to costimulation did not require RelB ( Figure 3B ) but was dependent on cRel ( Figure 3C ), mimicking B cell responses to solitary BCR stimulation ( Cheng et al., 2003 ; Grumont et al., 1998 Grumont et al., , 1999 .
To substantiate these conclusions, we utilized a newly developed mouse model for RelB dysfunction, in which RelB's ability to bind DNA was inactivated by substitution of three amino acids identified based on protein structure data. These RelB db/db mice phenocopy RelB −/− in all aspects examined thus far (data not shown). We isolated RelB db/db follicular B cells to ~85% purity ( Figure S2 ) and compared their proliferative responses with wild-type or Crel −/− CD23 + follicular B cells upon BAFFR+BCR costimulation. Analysis of CFSEstained follicular B cells revealed substantially enhanced B cell expansion in both wild-type and Relb db/db , but not in Crel −/− , genotypes ( Figure 3D ). Total cell number measurements reflect this requirement, as Crel −/− B cells decline much more rapidly than wild-type controls and Relb db/db shows no obvious deficiency in costimulation conditions ( Figure 3D , right). Computational deconvolution of the CFSE data confirmed that cRel is required not only for allowing B cells to enter the proliferative program (pFs) but also for Tdie, whereas RelB deficiency had no discernible effect ( Figure 3E ).
In sum, these studies indicate a differential requirement for cRel and RelB for BAFF's physiological function. When B cells are cultured in BAFF, its survival signals are mediated in part by RelB; however, when BAFF functions as a costimulus to BCR, we observed superactivation of cRel, which mediates the enhanced population expansion by increasing the proportion of cells entering the proliferative program.
BAFF Relieves p100/IκBδ Termination of cRel Activity
These observations seemed reminiscent of noncanonical pathway activation of NFκB RelA observed in LTβ-treated fibroblasts ( Basak et al., 2007 ) and led us to hypothesize that p100 not only functions as a precursor for p52 generation via processing but also for oligomerization to form the high-molecular-weight IκBsome complexes that contain IκBδ activity ( Figure 4A ). When p100 expression is high due to BCR-stimulated RelA and cRel activity, the latter mechanism might lead to post-induction repression of cRel akin to IκBδ-mediated repression of lipopolysaccharide-induced RelA activity in mouse embryonic fibroblasts (MEFs) ( Shih et al., 2009 ). BAFF as a costimulus with IgM might thus neutralize the IκBδ-mediated negative feedback to prolong canonical NFκB responses.
To examine this hypothesis, we first showed that the three canonical IκBs, IκBα, IκBβ, and IκBε, showed characteristic degradation at early and induction at late time points in response to anti-IgM was unchanged when BAFF was applied as a costimulus ( Figure S3C ) as was the IKK activity profile ( Figure S3D ). In contrast, p100 was not subjected to IgM-mediated initial degradation but rather was induced from 12 hr on, and this late induction was almost completely absent in costimulation conditions ( Figure 4B ). Further, cRel immunoprecipitates revealed substantial p100 interaction following 24 hr of IgM stimulation, but this was largely absent in the costimulation condition ( Figure 4C ). This time point coincides with the presence of superactivated cRel observed by electrophoretic mobility shift assay (EMSA; Figure 2F ). In contrast, IκBα and IκBε interaction with cRel was similar between IgM-stimulated and BAFF-costimulated cells, with similar transient reduction at the early 3 hr time point. In sum, these observations support the hypothesis that p100 forms an inhibitory IκBδ-containing complex, which limits cRel activity during BCRtriggered B cell expansion and which may be neutralized by BAFF-costimulation to prolong cRel activation.
To test this hypothesis more quantitatively (and thus determine whether it provides a sufficient explanation) and develop a research tool that may complement wet lab experimentation, we constructed a mathematical model of the NFκB-signaling system in B cells, capable of responding to both canonical and noncanonical signals induced by BCR and BAFFR. Development of the mathematical model began with delineation of the model's topology, based on previously established models of lesser scope. We distinguish between reactions that control IκB synthesis and degradation ( Figure S4A ) and those that control NFκB monomer synthesis, dimerization, and interactions of dimers with IκBs ( Figure S4B ). The former represents an extension of the previously published four-IκB model ( Basak et al., 2007 ; Shih et al., 2009 ) , and the latter is an extension of a model of RelA and RelB dimers in dendritic cells ( Shih et al., 2012 ) to include cRel as well (see also Tables S1 and  S2 ). Thus, we account for all p50-and p52-containing dimers and the associated 19 NFκB-IκB complexes. The two topologies are connected not only via protein-protein interactions but also via NFκB-dependent synthesis control and the dual roles of the Nfkb2 gene product p100 as a precursor not only for the NFκB dimerization partner p52 but also for the IκBδ activity contained within the multimeric IκBsome. Data in Figures 1, 2 , and 3 and quantitation of polypeptides ( Figure S5 ; Table S3 ) provide an extensive training set to achieve a B-cell-specific parameterization.
To account for cell-to-cell heterogeneity of B cell responses, each condition was simulated with distributed kinase input profiles that may result from heterogeneous BCR-induced signaling ( Shinohara et al., 2014 ;  Figure S6 ); their average conforms to the experimentally measured profiles of IKK activity ( Figure S3D ). The similarly averaged simulations of IκB and NFκB dynamics show that cRel-containing dimers are transiently induced, peaking at about 5 hr before returning to basal levels in response to BCR or BAFF-R stimulation alone ( Figure 4D , third row), whereas RelB-containing dimers are induced late and in a sustained and BAFF-R-dependent manner ( Figure 4D , fourth row); these simulation outputs match our biochemical analysis at late times ( Figure 3A) , though early RelB activity observed experimentally eludes the present version of the model. Finally, simulation of the costimulation scenario ( Figure 4D , third column) reveals a RelB profile that is surprisingly unchanged from the BAFF-alone condition and a cRel profile that shows superactivation at both early (1-4 hr) and late times (20-40 hr). Whereas early superactivation coincides with elevated NEMO-IKK activity, late superactivation does not. Instead, late cRel superactivation coincides with a BAFF-and NIK-dependent reduction in p100/IκBδ abundance at late times, which neutralizes its IgM-driven hyperexpression. In sum, mathematical modeling demonstrates that kinetic considerations alone are sufficient to account for context-specific NFκB effectors of BAFF-R signaling without the need to invoke context-specific molecular mechanisms.
p100/IκBδ Limits cRel-Mediated B Cell Expansion
The mathematical model encapsulates the key hypothesis that BAFF functions to relieve IκBδ-mediated termination of cRel activity. Model simulations suggested that a 2-fold reduction in the Nfkb2 mRNA synthesis rate, akin to Nfkb2 heterozygosity, would result in reduced p100 protein in both basal and IgM-stimulated conditions in silico ( Figure 5A ), which was confirmed in cells ( Figure 5B ). Unlike Nfkb2 −/− mice, we found that Nfkb2 +/− mice showed normal follicular B cell populations ( Figures S7A and S7B) . Further, the model predicted that the amount of inhibited cRel-p100 complex following 24 hr of antiIgM stimulation would be reduced in Nfkb2 +/− B cells compared to the wild-type controls ( Figure 5C ). Indeed, quantitative cRel coimmunoprecipitation revealed severely diminished p100 interaction in anti-IgM-treated Nfkb2 +/− cells akin to those in BAFF-treated wild-type cells ( Figure 5D ). Next, model simulations predicted that Nfkb2 heterozygosity would enhance cRel activity at late times (24-48 hr; Figure 5E ). Biochemical analysis confirmed this prediction, showing increased cRel DNA-binding activity at late times as compared to wild-type cells ( Figure 5F ). These studies establish the expression level of p100 as a remarkably sensitive parameter in terminating NFκB activity via the presumed multimeric IκBδ.
To examine the cell biological consequence of enhanced cRel activation in Nfkb2 +/− B cells, we undertook CFSE dye dilution studies, which revealed that anti-IgM-stimulated Nfkb2 +/− B cells showed enhanced B cell expansion over wild-type controls ( Figure 5G ). Computational deconvolution ( Figure 5H ) showed that this increased expansion was primarily due to increases in the fraction of cell entering the proliferative program (pF), moderately for generation zero (pF0) but more so for subsequent generations (pF2, pF3, pF4, etc.). Further, survival times (Tdie0) increased, mimicking costimulation conditions. Our biochemical analysis, combined with enhanced proliferative capacity, document that Nfkb2 heterozygous B cells possess a heightened BCR responsiveness in vitro. To test whether this phenotype holds true in vivo, we immunized Nfkb2 +/− mice with 4-hydroxy-3-nitrophenyl keyhole limpet hemocyanin (NP-KLH) to induce a T-dependent antigen response and then examined antibody levels in sera ( Figure 5I ). We found a significant increase of NP-specific IgM, IgG3, and IgG1 levels in Nfkb2 +/− mice compared with wildtype 10 and 28 days postimmunization. We also note an increase in total Ig Nfkb2 +/− mice.
These data are noteworthy because Nfkb2-knockouts, which lack not only IκBδ (deficient in Nfkb2 +/− ) but also survival-associated RelB:p52 (present in Nfkb2 +/− ), show reduced mature B cells and diminished antibody responses ( Caamaño et al., 1998 , Franzoso et al., 1998 . Together, our data support the notion that the IκBδ-containing IκBsome plays a key role in terminating antigen-triggered B-proliferative responses and humoral immunity by limiting the duration of cRel transcription factor activity.
Nfkb1/p105 Stabilizes IκBδ to Control B Cell Expansion
To further test the model that the IκBδ-containing IκBsome is critical for terminating cReldriven B-cell-proliferative responses, we sought ways to perturb IκBsome formation. Previous biochemical studies described an assembly pathway for high-molecular-weight IκBsome involving mutually stabilizing interactions between the Nfkb1 and Nfkb2 gene products p105 and p100 ). In addition, p50 and p52 have been described to compete for a limited pool of activation-domain-containing NFκB proteins, RelA, cRel, and RelB ( Basak et al., 2008 ) . Both mechanisms determine the balance between IκBsome formation by p100 and its processing to p50/p52. These interdependencies in p100 and p105 ( Figure 6A ) allow for compensation for the absence of p50 by p52 ( Hoffmann et al., 2003 ) but with concomitant loss of p100 and lymphotoxin-beta receptor responsiveness in Nfkb1 −/− MEFs ( Basak et al., 2008 ) and lymph node formation in Nfkb1 −/− mice ( Lo et al., 2006 ) .
We examined whether Nfkb1 might be required for efficient IκBδ function during IgMtriggered B cell expansion. Examination of B cell populations in Nfkb1-deficient mice was similar to wild-type controls ( Figure S7C ), and our quantitative gene-expression analysis confirmed that the steady-state and inducible levels of Nfkb2 mRNA are similar in Nfkb1 −/− and wild-type B cells ( Figure S7D ). However, immunoblot analysis of Nfkb1 −/− B cell extracts indicated lower levels of p100 protein and elevated levels of p52 ( Figure 6B ). This decrease in the available p100 pool was also evident in the cytoplasmic fraction ( Figure 6C ). Immunoblotting nuclear fractions, we detected elevated cRel levels in BCR-stimulated Nfkb1 −/− B cells over wild-type counterparts ( Figure 6D ). These data suggest that Nfkb1 deficiency destabilizes p100-containing IκBδ to neutralize its inhibition of cRel activity. Coimmunoprecipitation analysis confirmed that p100 was bound to a lesser extent to cRel in anti-IgM-treated Nfkb1 −/− B cells than wild-type controls ( Figure 6E ).
Next, we examined BCR-triggered B cell expansion with CFSE dye dilution analysis. FACS analysis revealed enhanced proliferative responses in Nfkb1 −/− B cells compared to wildtype controls ( Figure 6F ). Computational deconvolution identified that the phenotype was primarily due to a greater fraction of cells entering the proliferative program with only minor changes in cell division or survival times ( Figure 6G ). Although Nfkb1/p50 is a known dimerization partner of cRel, our data suggest that Nfkb1's primary role in antigenresponsive B cell expansion is to limit the proliferative program by Nfkb1/p105-stabilizing IκBδ. Previous studies established that BAFF engages the noncanonical NFκB-signaling pathway, which activates NFκB activity via NEMO-independent kinases NIK and IKK1. A hallmark of noncanonical NFκB activity is RelB:p52 activation. Although NIK, cRel, and RelA have been shown to be required for normal B cell homeostasis, no genetic evidence pointed to the necessity of RelB. Here, we showed that BAFF-induced survival of resting splenocytes in vitro is indeed RelB dependent ( Figure 3B ).
However, when employing BAFF as a costimulus during antigen-receptor-triggered B cell expansion, we found that RelB was dispensable ( Figure 3D ), prompting us to search for other relevant effectors. One clue was provided by the unbiased, software-aided analysis of the CFSE dye dilution data of BCR and BAFF/BCR-costimulated B cells: enhanced expansion was largely due to an increased fraction of cells entering the cell division program, particularly at later generations. B cell proliferation is known to be mediated by cRel ( Grumont et al., 1998 ) , and we found dramatic superactivation of cRel in costimulation conditions but little enhancement in RelB activity. Further, our transcriptomic studies identified enrichment of cRel-binding regulatory motif (Figures 2A and 2C ) and genetic cRel dependency ( Figure 2E ) in genes with enhanced expression during costimulation.
The TNF superfamily receptors, BAFF-R and transmembrane activator and CAML interactor (TNFRSF13B) (TACI), are expressed on all B cell subsets and mediate BAFF function ( Shulga-Morskaya et al., 2004 ) . Whereas TACI is known to activate the canonical NFκB pathway ( Marsters et al., 2000 ) , recent studies have also implicated BAFF-R ( Enzler et al., 2006 ) and shown that BAFF stimulation of Taci −/− B cells also leads to IκBα degradation and canonical pathway activation ( Shinners et al., 2007 ) . Although early cRel activation (3-8 hr) may be attributed to such canonical activation by TACI and BAFF-R, late cRel activity (24-48 hr) only appears in costimulation conditions ( Figure 3A ).
How does BAFF-R allow for late superactivation of cRel in proliferating B cells? One mechanism might be the generation of a cRel:p52 dimer as a result of enhanced p100 processing; we indeed saw increased amounts of p52 bound to cRel in coimmunoprecipitation experiments (data not shown), though this remained a minor component of the DNA-protein complex found in EMSAs. The primary mechanism appeared to be the derepression of cRel activity via the previously described IκBδ activity, which results from oligomerized Nfkb2 p100 ( Basak et al., 2007 ) within the high-molecularweight IκBsome . Indeed, progressive maturation of the IκBsome to a high-molecular-weight complex with potent NFκB inhibitor function begins with RelAresponsive expression of both p100 and p105 and requires their mutual interactions ( Basak et al., 2007 ; Savinova et al., 2009 ; Shih et al., 2009 ).
By describing the signaling network in mathematical terms, we could show that known molecular mechanisms and kinetic rate constants (experimentally determined or inferred within a reasonable range) are sufficient to account for the observed molecular and genetic phenomena in both maturing and proliferating B cells. Further, using computational simulations, we developed hypotheses that distinguished the IκBsome model from the alternative RelB:p52 model. Testing these hypotheses experimentally, we showed (1) that reduced p100 expression levels (with Nfkb2 heterozygous B cells) result in elevated levels of nuclear cRel at late times and increased B cell proliferation (rather than decreased proliferation that would be expected if RelB:p52 was the relevant effector) and (2) that disruption of the IκBsome assembly pathway (due to p105 deficiency) would also relieve cRel inhibition, resulting in enhanced expansion and mimicking the costimulated state. Our results do not contradict previous work that tonic canonical NFκB signaling in resting B cells is required for noncanonical RelB:p52 activation ( Shinners et al., 2007 ; Stadanlick et al., 2008 ) . The quantitative description of the network clarifies that low-RelA/cRel activity is required to generate p100 as a substrate for processing to p52 (as well as RelB; Basak et al., 2008 ) for RelB:p52 generation ( Shinners et al., 2007 ; Stadanlick et al., 2008 ) but that elevated p100 production, as it occurs in proliferating conditions, results in an excess of p100 molecules that then assemble into the IκBsome, which BAFF in turn neutralizes.
Our work here on the IκBsome's role in lymphocyte expansion may be a description of its physiological significance. Future studies may implicate it in other physiological functions. Indeed, phenotypes associated with C-terminal deletions of the Nfkb1 and Nfkb2 genes reported many years ago ( Caamaño et al., 1998 ; Migliazza et al., 1994 ) may best be understood in terms of disrupted IκBsome assembly. Further, cancer-associated mutations in B cell lymphoma or multiple myeloma affecting the noncanonical signaling pathway likely function by disrupting the normal buffering functions of the IκBsome ( Busino et al., 2012 ; Hailfinger et al., 2009 ; Lim et al., 2012 ) .
EXPERIMENTAL PROCEDURES B Cell Isolation, Proliferation, and Survival Analysis
Spleens were harvested from C57Bl6 wild-type or littermate Relb −/− , RelB db/db , Crel −/− , Nfkb1 −/− , and Nfkb2 +/− mice. For B cell isolation, homogenized splenocytes were incubated with anti-CD43 microbeads for 15 min at room temperature, washed with FACS buffer, and separated on LS column (Miltenyi Biotec). Purity was confirmed to be ~92%-95%. Marginal Zone and Follicular B Cell Isolation Kit (Miltenyi Biotec) was used for separation of follicular B cells from whole splenocytes, with a purity of 83%-87% CD23 + follicular B cells ( Figure S2 ). Complete media consisted of RPMI-1640, 10 mM HEPES, 0.055 mM β-mercaptoethanol, penicillin and streptomycin, and l-glutamine. B cells were stimulated with 5 µg/ml of Fab anti-mouse IgM (Jackson Immunology Research) and/or 50 ng/ml recombinant mouse BAFF (R&D Systems). In vitro proliferation assay was performed using CFSE tracking dye as described ( Hawkins et al., 2007 ) . Data were collected on a C6 Accuri (BD Biosciences) or FACSCalibur and analyzed with FlowJo software and FlowMax ( Shokhirev and Hoffmann, 2013 ) . B cell survival was determined by 7ADD staining using FlowJo for data analysis.
Biochemical Assays
Immunoblotting analysis, EMSAs, and kinase assays were conducted with standard methods as described previously ( Shih et al., 2012 ; Werner et al., 2005 ) and antibodies specific for RelA (Santa Cruz Biotechnology; sc372), RelB (sc226), cRel (sc71), IκBα (sc371), IκBε (sc7155), α-tubulin (sc226), p100, and p105 (Dr. Nancy Rice). For EMSAs focusing on cRel-DNA-binding activity, nuclear extracts are preincubated with RelA and cRel antibodies for 15 min on ice prior to addition of radiolabeled probe to ablate their respective DNAbinding activities. Similarly, nuclear extracts were preincubated with RelA and cRel antibodies or RelB and cRel antibodies when RelB-or RelA-DNA-binding activity was the focus, respectively. RNAeasy Mini Kit (QIAGEN) was used to purify RNA. cDNA synthesis performed with iScript cDNA Synthesis Kit (Bio-Rad). Quantitative RT-PCR was performed with SYBR Green PCR Master Mix reagent using the Δ(ΔCt) method with β-actin as normalization control, relative to unstimulated signals in wild-type B cells to derive fold induction.
RNA-Seq Analysis
Total RNA was isolated from 50 ng/ml BAFF-stimulated wild-type B cells following 8 and 30 hr of culture. mRNA was extracted from 2 µg total RNA using oligo (dT) magnetic beads and fragmented at high temperature using divalent cations. cDNA libraries were generated using the IlluminaTruSeq kits, and quantitation was performed using the Roche Light Cycler 480. Sequencing was performed on Illumina's HiSeq 2000, according to manufacturer's recommendations, and prepared for RNA sequencing analysis by BIOGEM core facility at University of California, San Diego. Reads were aligned to the mouse mm10 genome and RefSeq genes ( Kent et al., 2002 ; Waterston et al., 2002 ) with Tophat ( Trapnell et al., 2009 ) . Cufflinks CummRbund ( Trapnell et al., 2012 ) was used to ascertain differential expression of genes. Gene differential fragments per kilobase of transcript per million mapped reads were obtained from the cuffdiff program in Tuxedo RNA-seq analysis suite.
Immunization
The primary immune response to T-dependent Ag was assessed after intraperitoneal immunization with 50 µg of NP-KLH precipitated in alum. Sera were collected 10 and 28 days after challenge and tested by ELISA. Briefly, plates were coated with 10 µg/ml NP-BSA (Biosearch Technologies) and sera were assessed at 1/100,000 dilution. Bound antibodies (Abs) were detected with HRP-conjugated Abs to total mouse Ig or specific mouse isotypes (eBioscience and Santa Cruz Biotechnology).
Computational Modeling
The ordinary differential equations model of multi-NFκB control was adapted from previous iteration of the B cell IκB-NFκB-signaling model ( Alves et al., 2014 ) and a previous version of dendritic cell IκB-NFκB-signaling model ( Shih et al., 2012 ) to account for activities of RelA:p50, RelA:p52, RelB:p50, RelB:p52, cRel:p50, and cRel:p52 dimers (Table S1) . Parameterization of the reaction of the model (Table S2 ) included quantitative measurements of B cell protein abundances (Table S3) 
Animal Use
The animal protocols for this study were approved by the University of California, San Diego Animal Care and Use Committee. Generation of the RelB db/db mouse strain containing mutations of residues required for DNA-binding R117A/Y120A/E123A will be described elsewhere.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Antigenic stimulation leads to release of cRel-containing dimers into the nucleus, resulting in activation of cell division programs ( Grumont et al., 1998 ( Grumont et al., , 1999 (B) and (D) are representative of at least three experiments. Bar graphs in (C) summarize best-fit cellular parameters with the lognormal SD. Error bars in (E) SD; n = 3. *p < 0.05, **p < 0.01 by Student's t test. See also Figure S1 . (A) Proposed mechanism of IκBδ inhibition of cRel in BCR-stimulated B cells. In resting B cells, BAFF-R stimulation activates the NIK/IKK1 kinase complex that results in p100 processing, which allows for RelB:p52 nuclear translocation ( Figure 3A) . In activated B cells, continuous BCR stimulation activates cRel dimers, resulting in the expression of p100, which functions as a substrate for oligomerization to form the inhibitor IκBδ, which binds cRel, forming a negative feedback loop. During BAFF costimulation, the p100 buildup is prevented, allowing for persistent "superactivated" cRel. 
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